Quince Therapeutics, Inc. (QNCX): SCHEDULE 13G/A filed May 15, 2026

Form type

SCHEDULE 13G/A

Filing date

May 15, 2026

Accession number

0001104659-26-062688

Filer

Quince Therapeutics, Inc. (CIK 1662774)